Comparison of Two Corticosteroid Regimens for Post COVID-19 Diffuse Lung Disease

NCT04657484 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Post COVID-19 Diffuse Lung Disease

Interventions

DRUG: Medium dose prednisolone
DRUG: Low dose prednisolone

Sponsor

Post Graduate Institute of Medical Education and Research, Chandigarh